NIAID Site Search

Peter Rebeiro, Ph.D., of the Vanderbilt University Medical Center K01 sample application

Last Reviewed: March 31, 2025

Information about Father of the NIH, Dr. Kinyoun, and his role in fighting the plague in San Francisco.

Last Reviewed: August 28, 2012

Kinyoun has long seemed an indistinct and mysterious character in American biomedical science. Was he a seminal figure or merely a man in the right place at the right time whose role might just as well have been filled by another? Was he a visionary who saw and brought about the future of biomedical science, or an ordinary man of average skills? Would the NIH exist today without him, and if so, in

Last Reviewed: August 28, 2012

Background information about the childhood experiences of Dr. Joseph Kinyoun, Father of the NIH.

Last Reviewed: August 28, 2012

Liu Application

Last Reviewed: November 5, 2024

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: February 9, 2024

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

NIH's Dr. Joseph Kinyoun entered the Marine-Hospital Service (MHS) on October 4, 1886 in a key position at the Staten Island quarantine station.

Last Reviewed: August 28, 2012

Sample application from Yingru Liu, Ph.D., for Small Business Innovation Research (SBIR) Phase II grant (R44).

Last Reviewed: November 25, 2022

Sample application from Peter Rebeiro, Ph.D., for Mentored Research Scientist Development Award (K01) grant.

Last Reviewed: November 29, 2022

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Sample application from Samantha Lynne Schwartz, Ph.D., for National Research Service Award (NRSA) individual fellowship (F31) grants.

Last Reviewed: March 16, 2023

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018

Dr. Barry received his Ph.D. in organic and bio-organic chemistry in 1989 from Cornell University. He joined NIAID following postdoctoral research at Johns Hopkins University. In 1998, he was tenured as chief of the TBRS. Dr. Barry is a member of several editorial boards, has authored more than 300 research publications in tuberculosis, and is the most cited researcher in the field, according to ScienceWatch.com.

Last Reviewed: January 12, 2024

This page may be helpful if you're a postdoctoral researcher* who eventually wants to be principal investigator (PI) of your own lab, most likely as a faculty member at an academic institution. *For our purposes, we assume that you have already joined a mentor's lab. Also, we use mentor in the singular, but you may have more than one. Table of Contents Laying the Groundwork Make the Most of Your

Last Reviewed: March 7, 2025

Information for researchers about which changes can be made to grants independently and which require NIAID permission.

Last Reviewed: September 29, 2023

TBRS is a multidisciplinary group composed of chemists, microbiologists, veterinarians, imaging scientists, and clinicians with a shared objective of improving chemotherapy for tuberculosis (TB) patients. Projects span chemical biology, medicinal chemistry, host-pathogen interactions, animal models of experimental chemotherapy, and experimental medicine clinical studies in TB patients.

Last Reviewed: March 11, 2025

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024

The 202nd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, September 12, 2022. Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:44 a.m. and from 1

Last Reviewed: January 27, 2023